The DOI matches its Crossref record; 413 of the 413 references it cites were found in a registry or an index.
Understanding and targeting resistance mechanisms in cancer
Open accessAbstract
Resistance to cancer therapies has been a commonly observed phenomenon in clinical practice, which is one of the major causes of treatment failure and poor patient survival. The reduced responsiveness of cancer cells is a multifaceted phenomenon that can arise from genetic, epigenetic, and microenvironmental factors. Various mechanisms have been discovered and extensively studied, including drug inactivation, reduced intracellular drug accumulation by reduced uptake or increased efflux, drug target alteration, activation of compensatory pathways for cell survival, regulation of DNA repair and cell death, tumor plasticity, and the regulation from tumor microenvironments (TMEs). To overcome cancer resistance, a variety of strategies have been proposed, which are designed to enhance the effectiveness of cancer treatment or reduce drug resistance. These include identifying biomarkers that can predict drug response and resistance, identifying new targets, developing new targeted drugs, combination therapies targeting multiple signaling pathways, and modulating the TME. The present article focuses on the different mechanisms of drug resistance in cancer and the corresponding tackling approaches with recent updates. Perspectives on polytherapy targeting multiple resistance mechanisms, novel nanoparticle delivery systems, and advanced drug design tools for overcoming resistance are also reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 401–413 of 413
Attaoua, C., Vincent, L., Jaoued, A. A., Hadj‐Kaddour, K., Baï, Q., Vos, J. D., Vian, L., & Cuq, P. (2014) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12093 · Cited by 17
Medina‐Sansón, A., Ramírez-Pacheco, A., Moreno-Guerrero, S. S., Dorantes-Acosta, E. M., Sánchez-Preza, M., & Reyes‐López, A. (2015) · BioMed Research International · doi:10.1155/2015/309491 · Cited by 16
Yang, Y., Teng, Q., Wu, Z., Wang, J., Lei, Z., Lusvarghi, S., Ambudkar, S. V., Ji, N., & Chen, Z. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01512-0 · Cited by 16
Self-citationNatural Product as Substrates of ABC Transporters: A Review
Chen, X.-Y. (2021) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/22123970mte01mzcvy · Cited by 16
Liu, J., Huang, W., Lee, K., Tung, S., Chen, C., & Chang, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27073 · Cited by 15
Wu, S., Wen, F., Li, Y., Gao, X., He, S., Liu, M., Zhang, X., & Tian, D. (2016) · Tumor Biology · doi:10.1007/s13277-015-4691-5 · Cited by 13
Paolo, V. D., Fulci, C., Rotili, D., Luca, A. D., Tomassi, S., Serra, M., Scimeca, M., Geroni, C., Quintieri, L., & Caccuri, A. M. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114060 · Cited by 13
ABC Transporters in Human Diseases: Future Directions and Therapeutic Perspectives
Falguières, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084250 · Cited by 8
The M476W/Q482H mutation of procaspase-8 restored caspase-8-mediated apoptosis
Li, M., Wei, L., Zhang, X., Zhang, Y., Jiang, J., & Liu, P. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.023 · Cited by 7
Menezes, T. M., Assis, C. R. D., Cintra, A. J. L., dos Santos, R. C. S., do Vale, W. K. M., Martins, R. M. G., Bezerra, R. D. S., Seabra, G. D. M., Li, C., & Neves, J. L. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00521 · Cited by 7
Deb, B., George, I. A., Sharma, J., & Kumar, P. (2020) · Methods in molecular biology · doi:10.1007/978-1-4939-9744-2_10 · Cited by 6
Oliver, J. A., Ortíz, R., Jiménez‐Luna, C., Cabeza, L., Perazzoli, G., Caba, O., Mesas, C., Melguizo, C., & Prados, J. C. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00093-8 · Cited by 6
Dellett, M., O’Hagan, K., Colyer, H. A. A., & Mills, K. (2010) · Biomarkers in Cancer · doi:10.4137/bic.s3185 · Cited by 4
Cited by
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Garg, P., Malhotra, J., Kulkarni, P., Horne, D., Salgia, R., & Singhal, S. S. (2024) · Cancers · doi:10.3390/cancers16132478 · Cited by 339
Overcoming Barriers in Cancer Biology Research: Current Limitations and Solutions
(2025) · doi:10.3390/cancers17132102 · Cited by 44
Huo, X., Jiang, S., Wu, S., Lian, Q., & Chen, H. (2025) · Liver Research · doi:10.1016/j.livres.2025.01.002 · Cited by 12
Zahedifard, Z., Mahmoodi, S., & Ghasemian, A. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2738 · Cited by 12
Hypoxic microenvironment in cancer: role in metabolic reprogramming
Sureka, N., Maheshwari, R., Agravat, A., Singhal, S., Zaman, S., Rishi, B., Siraj, F., Zaheer, S., & Misra, A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1771365 · Cited by 11
Metadata
- Authors
- Lei, Z., Tian, Q., Teng, Q., Wurpel, J. N. D., Zeng, L., Pan, Y., & Chen, Z.
- Venue
- MedComm
- Publisher
- Wiley
- Published
- 2023-05-22
- Volume
- 4
- Issue
- 3
- Pages
- e265-e265
- ISSN
- 2688-2663 (ISSN-L)
- OpenAlex
- W4378082489
- Cited by
- 347
- References
- 413
- FWCI
- 35.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.